Search Within

Gynecology Disease Management Team

Formats
  1. Journal Article (2473)
  2. Meeting Abstract (2112)
  3. Book Section (226)
  4. Review (135)
  5. Editorial (88)
  6. Guidelines (39)
  7. Correspondence (19)
  8. Conference Paper (16)
  9. Miscellaneous (13)
  10. Research Letter (12)
  11. Book Whole (11)
Groups
  1. Surgery (2362)
  2. Department of Medicine (2268)
  3. Solid Tumor Oncology Division (2217)
  4. GDMT, Surgery (1974)
  5. GDMT, Medicine (1910)
  6. Gynecologic Medicine Service (1877)

More Groups

People
  1. Nadeem Abu-Rustum (902)
  2. Robert Soslow (797)
  3. Dennis Chi (716)
  4. Britta Weigelt (646)
  5. Carol Aghajanian (615)
  6. Mario Leitao (582)

More People

Years
  1. 2025 (161)
  2. 2024 (308)
  3. 2023 (332)
  4. 2022 (361)
  5. 2021 (308)
  6. 2020 (356)

More Years

Publications
  1. Gynecologic Oncology (950)
  2. Journal of Clinical Oncology (543)
  3. Modern Pathology (354)
  4. International Journal of Gynecological Cancer (321)
  5. Laboratory Investigation (311)
  6. International Journal of Radiation Oncology, Biology, Physics (223)

More Publications

Publishers
  1. Elsevier B.V. (1001)
  2. American Society of Clinical Oncology (598)
  3. Lippincott Williams & Wilkins (584)
  4. Elsevier Inc. (481)
  5. Nature Publishing Group (424)
  6. Nature Research (356)

More Publishers

Results (5144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sensitive HLA-independent T cell receptors overcome tumor antigen heterogeneity in solid tumors
    Meeting Abstract

    Hanina, S.; Park, T.; Lopez, M.; Rajasekhar, V.; Mansilla-Soto, J.; Haubner, S.; Zhao, H.; Banerjee, P.; Koche, R.; Hamard, P. J.; more...
    Molecular Therapy (2025)

    Fulltext@MSK | Save
  • Minimally invasive simple hysterectomy in low-risk cervical cancer: A single-arm trial with stopping rules (LAcc & SHape - LASH trial)
    Meeting Abstract

    Bizzarri, N.; Querleu, D.; Ramirez, P. T.; Plante, M.; Giannarelli, D.; Falconer, H.; Abu-Rustum, N. R.; Cibula, D.; Martinez, A.; Laas, E.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • A first-in-human phase 1 study Of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors (trial in progress)
    Meeting Abstract

    Ray-Coquard, I. L.; O'Malley, D. M.; Oaknin, A.; Pothuri, B.; Lorusso, D.; Eskander, R. N.; Westin, S. N.; Lakhani, N.; McKean, W. B.; Koyama, T.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • An open-label, multicentre, phase 2 study of trastuzumab deruxtecan in patients with HER2-expressing solid tumours: DESTINY-PanTumor02 Part 2
    Meeting Abstract

    Oaknin, A.; Lee, J. Y.; Makker, V.; Oh, D. Y.; Anoka, C.; Jung, L.; Puvvada, S.; Simões, J.; Meric-Bernstam, F.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Multimodal AI modeling of clinical panel-based sequencing for HRD detection in ovarian cancer
    Meeting Abstract

    Alsaafin, A.; Pollard, T.; Aukerman, A. T.; Boehm, K.; Pasha, A.; Moore, D.; Rusk, N.; Begum, A.; Sullivan, M. W.; Graves, S.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Phase I/II clinical investigation of invikafusp alfa, a first-in-class TCR-beta chain-targeted bispecific antibody, as monotherapy in patients with anti-PD(L)1-resistant, antigen-rich gastrointestinal (GI) cancers
    Meeting Abstract

    Fernandez, E. E.; Garralda, E.; Parikh, A.; Italiano, A.; Hollebecque, A.; Marabelle, A.; Friedman, C.; Sullivan, R.; Tschernia, N.; Juarez, M. M. H.; more...
    Annals of Oncology (2025)

    Fulltext@MSK | Save
  • Sexual health in postmastectomy breast reconstruction patients and value of an intervention: A qualitative study
    Journal Article

    Kim, M.; Gilliland, J. L.; Jiang, C. Z.; Parnes, M. F.; Carter, J.; Tadros, A. B.; Mehrara, B. J.; Nelson, J. A.; Stern, C. S.
    Journal of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Gauging the magnitude of missed opportunity for ovarian cancer prevention
    Journal Article

    Moufarrij, S.; Hazimeh, D.; Rockwell, T.; Ettorre, V.; Dagher, C.; Abu-Rustum, N. R.; Chi, D. S.; Long, K. C.; Stone, R. L.
    JAMA Surgery (2025)

    Fulltext@MSK | Save
  • Detection and characterization of RB1 mosaicism in patients with retinoblastoma receiving cfDNA test
    Journal Article

    Gao, C.; Patel, J.; Robbins, M.; Gedvilaite, E.; Bowman, A. S.; Arora, K.; Vanderbilt, C.; Brannon, A. R.; Friedman, D. N.; Kennedy, J.; more...
    JAMA Ophthalmology (2025)

    Fulltext@MSK | Save
  • Randomized study evaluating optimal dose, efficacy, and safety of E7386 plus lenvatinib versus treatment of physician's choice in advanced/recurrent endometrial carcinoma previously treated with platinum-based chemotherapy and immune checkpoint inhibitors
    Journal Article

    Eskander, R. N.; Lee, J. Y.; Mirza, M. R.; Lorusso, D.; MacKay, H.; Ray-Coquard, I.; Oaknin, A.; Gonzalez-Martin, A.; Hasegawa, K.; Corr, B. R.; more...
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save